MCL-1在BCL/ABL抗凋亡信号传导中的作用

批准号:
30170393
项目类别:
面上项目
资助金额:
6.0 万元
负责人:
任汉云
依托单位:
学科分类:
H0809.白血病
结题年份:
2002
批准年份:
2001
项目状态:
已结题
项目参与者:
董文川、陈欢、韩伟、张宝珍、丁昊伟、杨钟波、徐红
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
慢性髓性白血病(CML)是由增强BCR/ABL酪氨酸活性进而激活下游信号传导途径并抑制细胞凋亡所致。本研究拟通过阻断BCR/ABL下游信号传导途径观察对CML细胞增殖和凋亡以及对Mcl-1等抗凋亡基因表达的影响,阐明MCL-1 在BCR/ABL抗凋亡信号传导中的作用和地位,MCL闹瘟铺峁├砺刍〔⑻剿餍碌姆椒ā
英文摘要
To investigate the effect of STI571, an inhibitor of tyrosine kinase, on the proliferation and apoptosis of chronic myelogenous leukemia (CML) cells and the possible apoptosis-inducing mechanism, and also to investigate the possible targeted genes that regulated by the signaling transduction pathways of BCR/ABL , and the effect of these pathways on the biologic functions of CML cells. Methods K562 cell line was used to observe the effect of tyrosine kinase inhibitor STI571 and specific inhibitors of PI3K and MAPK on CML cells. Proliferation and cytotoxity were analyzed by MTT assay. The apoptoic cells were labelled with Annexin V-FITC and PI and then analyzed by flow cytometry. The expression of apoptotic-related proteins in K562 cell were determined by western blotting with specific antibodies. Results STI571 can significantly inhibit the proliferation and induce apoptosis of K562 cells in a dose and time-dependent way. Coincidently, the protein phosphorylation on tyrosine residues is reduced and the expression of anti-apoptotic protein Mcl-1 and Bcl-xl are down-regulated after exposure to STI571. Inhibition of MAPK or PI3-Kinase pathways can inhibit the proliferation of K562 cells but cannot induce apoptosis significantly. However, the suppression of proliferation was more pronounced and apoptosis of K562 cells could be induced when inhibited these two pathways simultaneously. The expressions of both Mcl-1 and Bcl-xl were down-regulated after inhibiting the signal transduction pathways, this coincidences with the level of the growth inhibition and apoptosis Conclusions STI571 can induce the apoptosis of CML cells through down-regulating the expression of Mcl-1 and Bcl-xl. These two gene expressions are regulated by the down-stream pathways of BCR/ABL. This may be responsible for the anti-apoptotic mechanism of CML cells and suggests that Mcl-1 and Bcl-xl may play an important role in anti-apoptotic process of CML cells.
专著列表
科研奖励列表
会议论文列表
专利列表
次级淋巴器官微环境对MDSC及相关细胞的调控及其在诱导异基因造血干细胞移植免疫耐受中的作用
- 批准号:81970160
- 项目类别:面上项目
- 资助金额:55.0万元
- 批准年份:2019
- 负责人:任汉云
- 依托单位:
促T细胞CCR7表达诱导异基因造血干细胞移植后免疫耐受的机制研究
- 批准号:81570160
- 项目类别:面上项目
- 资助金额:60.0万元
- 批准年份:2015
- 负责人:任汉云
- 依托单位:
靶向抑制CCR5功能及表达预防急性GVHD免疫学机制的研究
- 批准号:81370667
- 项目类别:面上项目
- 资助金额:75.0万元
- 批准年份:2013
- 负责人:任汉云
- 依托单位:
间充质干细胞对异基因T细胞体内趋化影响机制的研究
- 批准号:81070448
- 项目类别:面上项目
- 资助金额:34.0万元
- 批准年份:2010
- 负责人:任汉云
- 依托单位:
间充质干细胞改变异基因T淋巴细胞趋化特性及其机制的研究
- 批准号:30940030
- 项目类别:专项基金项目
- 资助金额:10.0万元
- 批准年份:2009
- 负责人:任汉云
- 依托单位:
慢性粒细胞白血病STI571耐药分子机制和有效替代治疗策略的研究
- 批准号:30371612
- 项目类别:面上项目
- 资助金额:20.0万元
- 批准年份:2003
- 负责人:任汉云
- 依托单位:
慢性髓性白血病抗信号传导治疗的实验研究
- 批准号:39770833
- 项目类别:面上项目
- 资助金额:12.0万元
- 批准年份:1997
- 负责人:任汉云
- 依托单位:
酪氨酸激活酶抑制剂诱导慢性髓性白血病细胞凋亡的研究
- 批准号:39570800
- 项目类别:面上项目
- 资助金额:8.0万元
- 批准年份:1995
- 负责人:任汉云
- 依托单位:
国内基金
海外基金
